Seeking Alpha

InterMune (ITMN +6.1%) rallies after Wells Fargo notes French regulators gave a favorable rating...

InterMune (ITMN +6.1%) rallies after Wells Fargo notes French regulators gave a favorable rating to the company's Esbriet lung disease drug. Wells believes the rating should allow InterMune to "negotiate premium pricing" for Esbriet. (previously)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|